A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time
StreetAccount Sector Summary - Healthcare Post-Market
Powered by FactSet Research Systems Inc.